Miriam Kidron - 17 Mar 2026 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Chief Scientific Officer, Director
Signature: /s/ Miriam Kidron
Issuer symbol: ORMP
Transactions as of: 17 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 18 Mar 2026, 17:46:58 UTC
Previous filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kidron Miriam	Chief Scientific Officer, Director	1185 AVENUE OF THE AMERICAS, THIRD FLOOR, NEW YORK	/s/ Miriam Kidron	18 Mar 2026	0001409232

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+119,558	+8.3%	$0.000000^*	1,568,222	17 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer.